Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Overview of attention for article published in Nature Immunology, February 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 103 X users
patent: 9 patents

Readers on

mendeley: 1273 Mendeley

Summary News Blogs X Patents

So far, Altmetric has seen 9 patents that reference this research output.

TARGETING SNX9 RESCUES RECOMBINANT T CELL IN ADOPTIVE THERAPY

Application WO-2024068010-A1

World Intellectual Property Organisation (WIPO)

IDENTIFICATION OF A COMMON PRECURSOR TO EFFECTOR AND REGULATORY TISSUE IMPRINTED CD4+ T…

Application WO-2024052433-A1

World Intellectual Property Organisation (WIPO)

Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof

Grant US-11767510-B2

United States of America

METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND…

Application WO-2023139242-A1

World Intellectual Property Organisation (WIPO)

Aseptic tissue processing method, kit and device

Grant US-11618877-B2

United States of America

Aseptic tissue processing method, kit and device

Grant US-11618878-B2

United States of America

EFFICIENT TCR GENE EDITING IN T LYMPHOCYTES

Application WO-2022204443-A1

World Intellectual Property Organisation (WIPO)

MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPY

Application WO-2021209627-A1

World Intellectual Property Organisation (WIPO)

ANTI-PVRIG AND ANTI-TIGIT ANTIBODIES FOR ENHANCED NK-CELL BASED TUMOR KILLING

Application WO-2021113831-A1

World Intellectual Property Organisation (WIPO)